Finding the 'Sweet Spot' for Dual Antiplatelet Therapy

TCT 2011 — SAN FRANCISCO — Customizing antiplatelet regimens to fit individuals should improve outcomes for drug-eluting stents, but even as stent technology has progressed, finding the 'sweet spot' for dual antiplatelet therapy remains elusive, researchers here explain in the exclusive video report.

Keywords: Transcatheter Cardiovascular Therapeutics


< Back to Listings